Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/NSRX/Capital expenditures

Nasus Pharma Ltd (NSRX) Capital expenditures

Nasus Pharma Ltd (NSRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$14,000FY2025
25
Fiscal yearValueYoY
FY2025$14,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More NSRX financial trends

NSRX RevenueNSRX Net incomeNSRX Net marginNSRX Gross profitNSRX Gross marginNSRX Operating incomeNSRX Operating marginNSRX Operating cash flowNSRX Free cash flowNSRX Return on equityNSRX Stock buybacksNSRX Dividends paidNSRX Total assetsNSRX Total liabilitiesNSRX Shareholders’ equityNSRX overview →